There is a reason why the trials are all in the US, there simply aren't enough patients in Australia to recruit into trials.
Simply can't run them here and can derive no accurate data.
The CU6 team is all ex-Algeta, they know how to do these.
ASX: CU6 Outlook., page-21
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.28 |
Change
0.170(2.78%) |
Mkt cap ! $1.989B | |||
| Open | High | Low | Value | Volume |
| $6.04 | $6.41 | $6.00 | $7.136M | 1.147M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 389 | $6.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.32 | 3098 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |